Thermo Fisher Scientific Inc.

NYSE:TMO

Medical - Diagnostics & Research

Healthcare
$692.74 +0.96%

+$4.45 today

Market cap
$256.67B
Beta
0.87
P/E (TTM)
25.3
EPS (TTM)
$18.44
Dividend yield
0.39%
52W Low $390.50High $643.99

Volume 1.99M

Average 2.23M

TMO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Thermo Fisher Scientific Inc.NYSE: TMO

Weighted Avg Shares · Q3 FY2026 · quarter ended Sep 2026

Weighted avg shares declines year over year

Q3 FY2026 weighted avg shares of 370M shares fell 2.1% year over year, in line with the -1.8% change in trailing-twelve-month weighted avg shares. Sequentially, it fell 0.3% from the prior quarter. Over 3 fiscal years it compounded at -1.4% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -2.1% toward the trailing-twelve-month pace of -1.8%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
370M-0.3% QoQ
Last fiscal yearDec 2025
376M-1.6% YoY
LTMSep 2026
372.25M-1.8% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-2.1%——
1 year-1.6%——
3-year CAGR-1.4%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
376M USD
Year-over-year change
-1.6%
4-year CAGR
-1.2%

Weighted Avg Shares vs competitors

How TMO compares with its peers on the latest reported figures

  • TMO's LTM Sep 2026 weighted avg shares of 372.25M shares is the 2nd highest of the 10 companies compared; the peer median is 152.05M shares.
  • Its year-over-year change of -1.8% is the 6th highest of 10, against a peer median of -1.7%.
  • Over three fiscal years its annual growth of -1.4% compares with a peer median of -1.8%.
TMO Competitors Peer median
Weighted Avg Shares for TMO and competitors
Company Period LTM YoY 3-year CAGR
DHRDanaher CorporationLTM Sep 2026706.08M -1.7%-0.8%
TMOThermo Fisher Scientific Inc.LTM Sep 2026372.25M -1.8%-1.4%
AAgilent Technologies, Inc.LTM Jul 2026282.75M -1.2%-1.8%
QGENQiagen N.V.LTM Jun 2026209.5M -4.1%-2.0%
TECHBio-Techne CorporationLTM Sep 2026156.12M -0.3%-0.3%
BRKRBruker CorporationLTM Jun 2026152.05M +0.3%+0.7%
RVTYRevvity, Inc.LTM Jul 2026113.64M -5.7%-3.5%
WATWaters CorporationLTM Jul 202674.85M +26.0%-0.3%
BIOBio-Rad Laboratories, Inc.LTM Jun 202626.9M -3.2%-2.9%
MTDMettler-Toledo International Inc.LTM Jun 202620.32M -2.9%-2.9%
Peer median (excluding TMO) 152.05M-1.7%-1.8%

Competitors are the stored peer set for TMO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue39.21B44.92B42.86B42.88B44.56B
Cost of Revenue19.58B25.9B25.66B25.15B26.32B
Gross Profit19.63B19.01B17.19B17.73B18.24B
Gross Margin50.1%42.3%40.1%41.3%40.9%
Research & Development1.41B1.47B1.34B1.39B1.4B
Selling, General & Admin7.91B9.02B8.41B8.68B8.73B
Operating Expenses9.32B10.49B9.75B10.07B10.13B
Depreciation & Amortization2.59B3.38B3.41B3.11B2.78B
EBITDA11.97B11.94B11.2B11.8B11.47B
EBITDA Margin30.5%26.6%26.1%27.5%25.7%
Operating Income10.32B8.53B7.45B7.66B8.11B
Operating Margin26.3%19.0%17.4%17.9%18.2%
Interest Income43M272M879M1.08B993M
Interest Expense536M726M1.49B1.65B1.42B
Other Income / Expenses(1.48B)(862M)(1.21B)(667M)(842M)
Income Before Tax8.84B7.66B6.24B7B7.27B
Pre-Tax Margin22.5%17.1%14.6%16.3%16.3%
Income Tax Expense1.11B703M284M657M547M
Net Income7.73B6.95B6B6.34B6.74B
Net Margin19.7%15.5%14.0%14.8%15.1%
EPS (Basic)19.6117.7315.5316.5817.77
EPS (Diluted)19.4617.6415.4516.5317.74
Weighted Avg Shares394M392M386M382M376M
Weighted Avg Shares (Diluted)397M394M388M383M377M

Thermo Fisher Scientific Inc.

NYSE:TMO

Intrinsic Alpha fair value

Locked

Current Price

$692.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.